JPS6336756B2 - - Google Patents
Info
- Publication number
- JPS6336756B2 JPS6336756B2 JP54093405A JP9340579A JPS6336756B2 JP S6336756 B2 JPS6336756 B2 JP S6336756B2 JP 54093405 A JP54093405 A JP 54093405A JP 9340579 A JP9340579 A JP 9340579A JP S6336756 B2 JPS6336756 B2 JP S6336756B2
- Authority
- JP
- Japan
- Prior art keywords
- tris
- reaction
- oligonucleotide
- oligonucleotides
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108091034117 Oligonucleotide Proteins 0.000 claims description 20
- 101001066878 Homo sapiens Polyribonucleotide nucleotidyltransferase 1, mitochondrial Proteins 0.000 claims description 9
- 102000002681 Polyribonucleotide nucleotidyltransferase Human genes 0.000 claims description 9
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 claims description 7
- 235000013928 guanylic acid Nutrition 0.000 claims description 7
- 239000004226 guanylic acid Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- QGWNDRXFNXRZMB-UUOKFMHZSA-N GDP Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O QGWNDRXFNXRZMB-UUOKFMHZSA-N 0.000 claims description 5
- 101710163270 Nuclease Proteins 0.000 claims description 4
- 241000589596 Thermus Species 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- QGWNDRXFNXRZMB-UHFFFAOYSA-N guanidine diphosphate Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O QGWNDRXFNXRZMB-UHFFFAOYSA-N 0.000 claims description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000000872 buffer Substances 0.000 description 8
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 239000002609 medium Substances 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 229920005654 Sephadex Polymers 0.000 description 4
- 239000012507 Sephadex™ Substances 0.000 description 4
- 241000868182 Thermus thermophilus HB8 Species 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 239000013615 primer Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000005342 ion exchange Methods 0.000 description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 3
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 2
- 108091034057 RNA (poly(A)) Proteins 0.000 description 2
- 241000589499 Thermus thermophilus Species 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 238000005199 ultracentrifugation Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- XFWPSMMTMBICQM-GWTDSMLYSA-N 2-amino-9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purin-6-one;phosphono dihydrogen phosphate Chemical compound OP(O)(=O)OP(O)(O)=O.C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O XFWPSMMTMBICQM-GWTDSMLYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- HOYWVKUPOCFKOT-UHFFFAOYSA-N [4-[(4-methoxyphenyl)methylideneamino]phenyl] acetate Chemical compound C1=CC(OC)=CC=C1C=NC1=CC=C(OC(C)=O)C=C1 HOYWVKUPOCFKOT-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000061 acid fraction Substances 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
- 235000011285 magnesium acetate Nutrition 0.000 description 1
- 239000011654 magnesium acetate Substances 0.000 description 1
- 229940069446 magnesium acetate Drugs 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000004816 paper chromatography Methods 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 108010068698 spleen exonuclease Proteins 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
【発明の詳細な説明】
本発明はオリゴヌクレオチドの製造法に関す
る。さらに詳しくは、グアニル酸を含むオリゴヌ
クレオチドの酵素的製造法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing oligonucleotides. More specifically, the present invention relates to a method for enzymatically producing oligonucleotides containing guanylic acid.
近来、核酸が生体の重要な機能である遺伝形質
の伝達や蛋白質合成などに果している役割が解明
されるにおよんで、その構造と機能の関連性をよ
り深く知ることがますます重要になつてきてい
る。そして所望の塩基配列を有するオリゴヌクレ
オチド即ち、既知塩基配列のオリゴヌクレオチド
を合成し、蛋白合成系に与える影響を調べること
によつて、構造と機能の関連を知ることも1つの
研究方法としてよくおこなわれている。このよう
な研究において用いられる試薬として、既知塩基
配列オリゴヌクレオチドを製造しようとする場
合、グアニル酸を含むオリゴヌクレオチドを製造
することは比較的難しい。 In recent years, as the role that nucleic acids play in important biological functions such as transmission of genetic traits and protein synthesis has been elucidated, it has become increasingly important to understand the relationship between their structure and function. ing. One research method is often used to learn the relationship between structure and function by synthesizing oligonucleotides with a desired base sequence, that is, oligonucleotides with known base sequences, and examining the effects on the protein synthesis system. It is. When attempting to produce oligonucleotides with known base sequences as reagents used in such research, it is relatively difficult to produce oligonucleotides containing guanylic acid.
本発明者等はグアニル酸を含むオリゴヌクレオ
チドの酵素的製造法を開発すべく検討した結果、
本発明に達成した。即ち本発明の要旨は、サーマ
ス(Thermus)属に属する細菌より得られるポ
リヌクレオチドホスホリラーゼを用いてオリゴヌ
クレオチドプライマーとグアノシンジリン酸とを
塩基特異的ヌクレアーゼ不存在下、20℃〜55℃で
反応させてグアニル酸を含むオリゴヌクレオチド
を得ることを特徴とするオリゴヌクレオチドの製
造法に存する。 The present inventors conducted studies to develop an enzymatic production method for oligonucleotides containing guanylic acid, and found that
This invention has been achieved. That is, the gist of the present invention is to react an oligonucleotide primer and guanosine diphosphate at 20°C to 55°C in the absence of a base-specific nuclease using polynucleotide phosphorylase obtained from a bacterium belonging to the genus Thermus . The present invention relates to a method for producing an oligonucleotide, which is characterized by obtaining an oligonucleotide containing guanylic acid.
さらに本発明を詳細に説明するに、サーマス
(Thermus)属に属する細菌としては、サーマス
サーモフイラス(Thermus thermophilus)、
サーマス フラバス(Termus flavus)等が挙
げられる。そしてこれらの菌株としては、サーマ
ス サーモフイラスHB8(ATCC27634、
InternationalJ.of Systematic Bacteriol.24、
102〜112に記載されている)、サーマス フラバ
スBS1、AT61、AT62(これらはAgr.Biol、
chem.36、2357〜2366に記載されている)等が挙
げられる。とくに、サーマス サーモフイラスが
好ましい。 To further explain the present invention in detail, the bacteria belonging to the genus Thermus include Thermus thermophilus ,
Examples include Termus flavus . These strains include Thermus thermophilus HB8 (ATCC27634,
InternationalJ.of Systematic Bacteriol. 24 ,
102-112), Thermus Flavus BS1, AT61, AT62 (these are Agr.Biol,
chem. 36 , 2357-2366). In particular, Thermus Thermofilas is preferred.
ポリヌクレオチドホスホリラーゼは、これらの
細菌から公知の方法(例えば、蛋白質、核酸、酵
素vol.13、No.9、845〜、またはThe Journal of
Biological Chemistry vol.243、No.2、231〜)
で分離精製することにより得ることができる。例
えば、サーマス サーモフイラスHB8を適当な
培地、例えばポリペプトン5g、酵母エキス4
g、グルコース1g、塩化ナトリウム2gおよび
水1000mlからなる培地で60℃〜85℃で通気撹拌下
に培養し、得られた菌体をアルミナ磨砕し、マグ
ネシウムイオンを含むトリス塩酸緩衝液で抽出
し、超遠心分離、硫安分画、カラムクロマトグラ
フイー、等電点分画法などを組合せて、ポリアク
リルアミドゲル電気泳動で単一に精製することが
できる。そしてこのサーマス サーモフイラス
HB8からのポリヌクレオチドホスホリラーゼは
Eur.J.Biochem.77、575〜583(1977)に記載され
ている。 Polynucleotide phosphorylase can be obtained from these bacteria by known methods (e.g. Proteins, Nucleic Acids, Enzymes vol. 13, No. 9, 845~, or The Journal of
Biological Chemistry vol.243, No.2, 231~)
It can be obtained by separating and purifying it. For example, Thermus Thermophilus HB8 is mixed with a suitable medium such as 5 g of polypeptone and 4 g of yeast extract.
The cells were cultured in a medium consisting of 1 g of glucose, 1 g of glucose, 2 g of sodium chloride, and 1000 ml of water at 60°C to 85°C with aeration and agitation, and the resulting bacterial cells were ground with alumina and extracted with Tris-HCl buffer containing magnesium ions. , ultracentrifugation, ammonium sulfate fractionation, column chromatography, isoelectric focusing, etc., and can be purified by polyacrylamide gel electrophoresis. And this Thermas Thermofilas
Polynucleotide phosphorylase from HB8 is
Eur. J. Biochem. 77 , 575-583 (1977).
本発明では、上述のようにして得られたポリヌ
クレオチドホスホリラーゼを用いて、オリゴヌク
レオチドプライマーとグアノシンジリン酸とを塩
基特異的ヌクレアーゼ不存在下、20℃〜55℃で反
応させてグアニル酸を含むオリゴヌクレオチドを
得る。オリゴヌクレオチドプライマーとしては、
目的に応じて任意の塩基配列のオリゴヌクレチド
が用いられる。具体例を挙げると、APAPAと通
称されている〔アデニリル−(3′→5′)〕2アデノシ
ン、APAと通称されている〔アデニリル−(3′→
5′)〕アデノシン、UPUPUと通称されている〔ウ
リジリル−(3′→5′)〕ウリジン等が挙げられる。
これらオリゴヌクレオチドは、市販品であつても
よいが、公知の方法で製造したものであつてもよ
い。例えば、APAPAはベーリンガー マンハイ
ム社のものが入手可能である。 In the present invention, using the polynucleotide phosphorylase obtained as described above, oligonucleotide primers and guanosin diphosphate are reacted at 20°C to 55°C in the absence of a base-specific nuclease to generate oligonucleotides containing guanylic acid. Obtain nucleotides. As an oligonucleotide primer,
Oligonucleotides with arbitrary base sequences can be used depending on the purpose. To give a specific example, A P A P A [adenylyl-(3'→5')] 2 adenosine, A P
5')] adenosine, [uridylyl-(3'→5')] uridine, commonly known as U P U P U, and the like.
These oligonucleotides may be commercially available products, or may be produced by known methods. For example, APAPA is available from Boehringer Mannheim.
グアノシンジリン酸の使用量は、オリゴヌクレ
オチドプライマーに対してモル比で当量近く、例
えば3〜4モル程度用いることが好ましい。反応
温度は、20℃〜55℃好ましくは30℃〜45℃から選
ばれる。温度がこの範囲より高いと、ポリグアニ
ル酸が多量に生成し好ましくない。一方、この温
度範囲より低いと、反応の進行が遅く好ましくな
い。 The amount of guanosine diphosphoric acid to be used is preferably close to an equivalent molar ratio to the oligonucleotide primer, for example, about 3 to 4 moles. The reaction temperature is selected from 20°C to 55°C, preferably 30°C to 45°C. If the temperature is higher than this range, a large amount of polyguanylic acid will be produced, which is not preferable. On the other hand, if the temperature is lower than this range, the reaction progresses slowly and is not preferable.
反応は、例えば、ポリヌクレオチドホスホリラ
ーゼ0.5単位/ml以上好ましくは1単位/ml〜13
単位/ml、塩化マグネシウムなどのマグネシウム
塩0.1mM〜3mM、オリゴヌクレオチドプライ
マー0.05mM〜2mM、グアノシンジリン酸0.5
mM〜10mMおよび50mMトリス塩酸緩衝液(PH
8.5)からなる反応液を塩基特異的ヌクレアーゼ
不存在下、上述のような温度で5時間〜45時間反
応させることにより行なわれる。 The reaction is carried out, for example, with polynucleotide phosphorylase of 0.5 units/ml or more, preferably 1 unit/ml to 13
units/ml, magnesium salt such as magnesium chloride 0.1mM to 3mM, oligonucleotide primer 0.05mM to 2mM, guanosin diphosphate 0.5
mM to 10mM and 50mM Tris-HCl buffer (PH
8.5) is reacted for 5 to 45 hours at the above-mentioned temperature in the absence of a base-specific nuclease.
以上のようにして反応させると、例えば、AP
APAからはAPAPAGおよびAPAPAPGPG、APA
からはAPAPGPG、UPUPUからはUPUPUPGが、
それぞれ得られる。 When the reaction is performed as described above, for example, A P
From A P A is A P A P AG and A P A P A P G P G, A P A
From A P A P G P G, from U P U P U, U P U P U P G,
You can get each.
反応終了後、生成物は常法に従い例えば、
DEAE−セフアデツクス(商標、Pharmacia Co.
製のイオン交換ゲル)のカラムクロマトグラフイ
ーにより分離すればよい。 After the reaction is complete, the product can be prepared using conventional methods, e.g.
DEAE (Trademark, Pharmacia Co.
They can be separated by column chromatography using ion-exchange gel (manufactured by the company).
本発明方法によれば、グアニル酸を含むオリゴ
ヌクレオチドを収率よく得ることができる。 According to the method of the present invention, oligonucleotides containing guanylic acid can be obtained in good yield.
以下本発明方法を実施例によりさらに詳細に説
明する。 The method of the present invention will be explained in more detail below with reference to Examples.
参考例
(サーマス サーモフイラスHB−8の培養、
ポリヌクレオチドホスホリラーゼの精製)
サーマス サーモフイラスHB−8
(ATCC27634)を1中にポリペプトン5g、酵
母エキス4g、グルコース1gおよびNaCl2gを
含む培地を用いて培養した。即ち、先ず約3mlの
上記培地の入つた20mlの試験管2本に上記菌を接
種し、インキユベーター(75℃)中に2昼夜放置
する。次いで上記培地1の入つた5の坂口コ
ルベン8本にこれを植えつぎ、75℃で一夜振とう
培養した。更にジヤーフアーメンター20、4基
にこれを植えつぎ、75℃で約8時間通気培養し、
対数増殖後期(クレツト数約400)で集菌し(シ
ヤープレス型連続遠心機使用)、生理食塩水約2
で軽く洗う。菌体は−20℃で凍結保存した。菌
体収量は培地80に対し、湿重量で約700gであ
つた。Reference example (Culture of Thermus thermophilus HB-8,
Purification of polynucleotide phosphorylase) Thermus Thermophilus HB-8
(ATCC27634) was cultured using a medium containing 5 g of polypeptone, 4 g of yeast extract, 1 g of glucose, and 2 g of NaCl. That is, first, the above bacteria are inoculated into two 20 ml test tubes containing about 3 ml of the above medium, and the tubes are left in an incubator (75°C) for 2 days and nights. Next, this was planted in 8 Sakaguchi Kolben bottles (No. 5) containing the above medium 1, and cultured with shaking at 75°C overnight. Furthermore, this was planted in 4 Jia Farmers 20, and aerated culture was carried out at 75℃ for about 8 hours.
Collect bacteria at the late stage of logarithmic growth (Cretz number approximately 400) (using a shear press type continuous centrifuge), and add approximately 2
Wash gently with The bacterial cells were stored frozen at -20°C. The yield of bacterial cells was about 700 g in wet weight based on 80 g of the culture medium.
上記菌体190gを酢酸マグネシウム0.01Mを含
む緩衝液に懸濁させ、Sigma Chemical CO.Ltd
製のデオキシリボヌクレアーゼを0.5μg/ml加え
てからアルミナ磨砕し、16000g20分遠心分離し、
その上清を次いで78000g18時間超遠心分離し、
その下から1/3までの上清を集める。沈澱区分は
Tris−Mg緩衝液で再抽出して、再度超遠心分離
し、その下から1/3の上清区分を取り合わせる。
次いでストレプトマイシンで核酸区分を除き、硫
安35〜55%の沈澱区分を集める。透析して脱塩し
たのち、QAE−Sephadex A−25〔フアルマイシ
ア社製イオン交換樹脂、(商標)〕カラムクロマト
グラフイにかける。0.15MのNaClで洗浄後、
NaCl0.15〜0.40Mの濃度勾配で流出させると、
0.3Mの近辺にポリヌクレオチドホスホリラーゼ
活性があらわれる。DEAEセルローズの短いカラ
ムで活性区分を濃縮し、1Mトリス(PH8.1)で流
出させ、これをSephadex G−200〔前述と同じ。〕
(2cm×72cm)のカラムクロマトグラフイにかけ、
0.01Mトリリス(PH8.2)、1mM MgCl2、
0.05M NaCl、1mM メルカプトエタノールで
流出する。 190 g of the above bacterial cells were suspended in a buffer containing 0.01M magnesium acetate, and Sigma Chemical CO.Ltd.
After adding 0.5 μg/ml of deoxyribonuclease (manufactured in Japan), the mixture was ground with alumina, centrifuged at 16,000 g for 20 minutes,
The supernatant was then ultracentrifuged at 78,000g for 18 hours.
Collect the supernatant from the bottom 1/3. Sedimentation classification is
Re-extract with Tris-Mg buffer, perform ultracentrifugation again, and collect the bottom 1/3 of the supernatant.
The nucleic acid fraction is then removed with streptomycin and the precipitated fraction containing 35-55% ammonium sulfate is collected. After desalting by dialysis, it is subjected to QAE-Sephadex A-25 (ion exchange resin manufactured by Pharmacia, trademark) column chromatography. After washing with 0.15M NaCl,
When flowing out with a concentration gradient of NaCl 0.15-0.40M,
Polynucleotide phosphorylase activity appears around 0.3M. The active fraction was concentrated on a short column of DEAE cellulose, eluted with 1M Tris (PH 8.1), and transferred to Sephadex G-200 [same as above. ]
(2cm x 72cm) column chromatography,
0.01M Trilith (PH8.2), 1mM MgCl 2 ,
Elute with 0.05M NaCl, 1mM mercaptoethanol.
これをWhatmanのMicrogranular DEAE−セ
ルロースDE−51〔Whatman社製イオン交換セル
ロース、(商標)〕に更に吸着させ、0.01Mトリス
塩酸(PH8.2)、1mM MgCl2及び1mM2−メ
ルカプトエタノールの緩衝液でNaCl0.1〜0.25M
の濃度勾配で流出させると、0.15M附近に活性が
でる。その活性部分を集めてヒドロキシアパタイ
トに吸着させ、0.01Mトリス−塩酸(PH7.4)、1
mM2−メルカプトエタノール、0.1M NaClの緩
衝液で、硫安0.1〜0.6Mまでの濃度勾配で流出さ
せると、0.2〜0.25Mの付近に活性ができる。次
にこの活性画分10mlを110ml容カラムクロマトグ
ラフで等電点分画した。1%のアンフオライン
〔LKB社製衝液、(商標)〕液を含むトリス−塩酸
緩衝液で、400V、40時間通電したのち、1mlず
つ分取し0.01mlを用いてポリアデニル酸合成活性
を測定し、活性区分を得た。各活性区分を集めア
ンフオラインを除くため透析を行ない、等電点
4.3、分子量200000(Sephadex G−200)の酵素
を得た。 This was further adsorbed onto Whatman's Microgranular DEAE-Cellulose DE-51 (ion-exchange cellulose manufactured by Whatman, (trademark)), and a buffer solution of 0.01M Tris-HCl (PH8.2), 1mM MgCl 2 and 1mM 2-mercaptoethanol was used. NaCl0.1~0.25M
When flowing out with a concentration gradient of , activity appears around 0.15M. The active part was collected and adsorbed onto hydroxyapatite, and 0.01M Tris-HCl (PH7.4) was added to
When ammonium sulfate is flowed out with a concentration gradient of 0.1 to 0.6M in a buffer solution of mM2-mercaptoethanol and 0.1M NaCl, activity occurs around 0.2 to 0.25M. Next, 10 ml of this active fraction was subjected to isoelectric point fractionation using a 110 ml column chromatograph. After applying electricity at 400 V for 40 hours in a Tris-hydrochloric acid buffer containing 1% ampholine [LKB buffer, (trademark)] solution, 1 ml was taken out and 0.01 ml was used to measure polyadenylic acid synthesis activity. The activity classification was obtained. Each active fraction was collected and dialysis was performed to remove ampholine, and the isoelectric point
4.3, an enzyme with a molecular weight of 200000 (Sephadex G-200) was obtained.
なお、ポリアデニル酸合成活性試験は、次のよ
うにしておこなつた。 The polyadenylic acid synthesis activity test was conducted as follows.
すなわち、トリス−塩酸(PH9.0)10mM、
MgCl2 1mM、ADP 1mM( 14C−ADP1μCi/
μmole)、(Ap)3A10μM及び上記酵素からなる全
量0.2mlの反応液を70℃、20分間反応させ、反応
後氷冷する。その25μをとり、Whatman3MM
〔Whatman社製紙、(商標)〕(1.5×10cm)の原
点に活性を付けたペーパークロマトグラフイーに
スポツトし、エタノール:1M酢酸アンモニウム
(PH5.5)、(1:1)で展開した。展開後原点の部
分を切りとり乾燥し、シンチレーシヨンカウンタ
ーで測定した。 That is, Tris-HCl (PH9.0) 10mM,
MgCl2 1mM, ADP 1mM ( 14C -ADP1μCi/
A total volume of 0.2 ml of a reaction solution consisting of 10 μM of µmole), (Ap) 3 A and the above enzyme is reacted at 70°C for 20 minutes, and after the reaction is cooled on ice. Take that 25μ and Whatman3MM
It was spotted on activated paper chromatography at the origin of Whatman Paper (trademark) (1.5 x 10 cm) and developed with ethanol:1M ammonium acetate (PH5.5) (1:1). After development, the origin was cut out, dried, and measured using a scintillation counter.
なお、この酵素の1単位は、70℃で1時間のう
ちにアデノシンモノリン酸が1μmoleであるよう
な量として定義される。 Note that 1 unit of this enzyme is defined as the amount that produces 1 μmole of adenosine monophosphate in 1 hour at 70°C.
実施例 1
(1) 反 応
塩化マグネシウム0.5mM、APAPA0.4mM、
グアノシンジリン酸2mM、上記参考例で得ら
れたポリヌクレオチドホスホリラーゼ1.61単
位/mlおよび50mMトリス塩酸緩衝液(PH8.5)
を含む全量1mlを37℃で20時間反応させた。反
応混合物を、0.5×25cmのDEAE−Sephadex
A−25(Pharmacia Co.製のイオン交換ゲル商
標)のカラムに加え、0.25Mから0.65M重炭酸
アンモニウム(全量200ml)の直線濃度勾配溶
出を流速約25ml/時間、室温でおこなつた。2
gを1フラクシヨンとして分取し、各フラクシ
ヨンの260nmにおける吸収を測定した。3つ
の吸収のピークが得られるが、そのうち、テト
ラマーと思われる2番目のピーク(40〜56番目
のフラクシヨン)を集め、凍結乾燥により脱塩
した後、次のようにして生成物の構造を決定し
た。Example 1 (1) Reaction Magnesium chloride 0.5mM, A P A P A 0.4mM,
Guanosin diphosphate 2mM, polynucleotide phosphorylase obtained in the above reference example 1.61 units/ml and 50mM Tris-HCl buffer (PH8.5)
A total volume of 1 ml containing the mixture was reacted at 37°C for 20 hours. The reaction mixture was transferred to a 0.5 x 25 cm DEAE-Sephadex tube.
A-25 (ion exchange gel trademark manufactured by Pharmacia Co.) column was added, and a linear concentration gradient elution from 0.25M to 0.65M ammonium bicarbonate (total volume 200ml) was performed at a flow rate of about 25ml/hour at room temperature. 2
g was collected as one fraction, and the absorption at 260 nm of each fraction was measured. Three absorption peaks are obtained, of which the second peak (40th to 56th fraction), which is thought to be a tetramer, is collected and desalted by freeze-drying, and the structure of the product is determined as follows. did.
上記のようにして得られた生成物0.5A260単
位、脾臓ホスホジエステラーゼ(Worthing−
ton Biochemical Cu.製)20μgおよび10mM
トリス・塩酸緩衝液(PH8.5)を含む反応混合
物10μを37℃で1時間反応させた。反応混合
物は、2次元薄層クロマトグラフイーで分離さ
れた。すなわち、セルロースプレート(7×7
cm2)にスポツトし、第1の方向(次元)をイソ
酪酸と0.5M NH4OHの5:3(容量比)混合
溶媒で、第2の方向(次元)をエタノールと
1M酢酸アンモニウム(PH5.5)の50:50(容量
比)混合溶媒で、展開した。UVでスポツトを
検出して切り出し、0.01MHClの0.6mlで抽出し
た。抽出物の吸収を260nmと280nmで測定し、
各成分の比率を決定した。ApとGを3.02:1.00
のモル比で得、このテトラマーが(Ap)3Gで
あることを確認した。なお、この反応において
(Ap)2Aから(Ap)3Gの収率は33%であつた。 0.5A 260 units of the product obtained as described above, spleen phosphodiesterase (Worthing-
ton Biochemical Cu.) 20μg and 10mM
10μ of the reaction mixture containing Tris/HCl buffer (PH8.5) was reacted at 37°C for 1 hour. The reaction mixture was separated by two-dimensional thin layer chromatography. That is, a cellulose plate (7 x 7
cm 2 ), the first direction (dimension) was treated with a 5:3 (volume ratio) mixed solvent of isobutyric acid and 0.5M NH 4 OH, and the second direction (dimension) was treated with ethanol.
It was developed with a 50:50 (volume ratio) mixed solvent of 1M ammonium acetate (PH5.5). Spots were detected by UV, cut out, and extracted with 0.6 ml of 0.01 MHCl. The absorption of the extract was measured at 260nm and 280nm,
The ratio of each component was determined. Ap and G 3.02:1.00
It was confirmed that this tetramer was (Ap) 3 G. In this reaction, the yield of (Ap) 3 G from (Ap) 2 A was 33%.
Claims (1)
得られるポリヌクレオチドホスホリラーゼを用い
てオリゴヌクレオチドプライマーとグアノシンジ
リン酸とを塩基特異的ヌクレアーゼ不存在下、20
℃〜55℃で反応させてグアニル酸を含むオリゴヌ
クレオチドを得ることを特徴とするオリゴヌクレ
オチドの製造法。1 Using polynucleotide phosphorylase obtained from a bacterium belonging to the genus Thermus, an oligonucleotide primer and guanosine diphosphate were combined in the absence of a base-specific nuclease for 20
A method for producing an oligonucleotide, the method comprising obtaining an oligonucleotide containing guanylic acid by reacting at a temperature of 55°C to 55°C.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9340579A JPS5618597A (en) | 1979-07-23 | 1979-07-23 | Production of oligonucleotide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9340579A JPS5618597A (en) | 1979-07-23 | 1979-07-23 | Production of oligonucleotide |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5618597A JPS5618597A (en) | 1981-02-21 |
JPS6336756B2 true JPS6336756B2 (en) | 1988-07-21 |
Family
ID=14081381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9340579A Granted JPS5618597A (en) | 1979-07-23 | 1979-07-23 | Production of oligonucleotide |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5618597A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59130221A (en) * | 1982-10-26 | 1984-07-26 | シ−テイエイ・フイナンツ・アクチエンゲゼルシヤフト | Improver and improvement for organ tissue in human and animal immunological movement zone |
GB8725606D0 (en) * | 1987-11-02 | 1987-12-09 | Soc D Etudes Prod Chimique | Preparation polynucleotides |
GB9108085D0 (en) * | 1991-04-16 | 1991-06-05 | Scras | Complexes of polyadenylic acid with polyuridylic acid |
-
1979
- 1979-07-23 JP JP9340579A patent/JPS5618597A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5618597A (en) | 1981-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0096547B1 (en) | Process for preparing uridine diphosphate-n-acetylgalactosamine | |
JP2795748B2 (en) | Method for producing nucleoside | |
US3444042A (en) | Purified replicases and their uses | |
Smith et al. | A Study of some Enzymes in Extracts of a Non-Capsulated Strain of Pneumococcus Concerned with Uridine Pyrophosphoǵlycosyl Metabolism | |
JPS6336756B2 (en) | ||
Merola et al. | Preparation and properties of soybean ribonuclease | |
JPS6360999B2 (en) | ||
JP3764755B2 (en) | "Production Method of Adenosine 5'-Triphosphate and Its Application" | |
Hiramaru et al. | Studies on Ribonucleases from Physarum polycephalum Purifiation and Characterization of Substrate Specificity | |
EP0566140B1 (en) | Method for producing dinucleoside polyphosphate, nucleoside polyphosphate or derivatives thereof | |
Georgatsos | Specificity of an alkaline deoxyribonuclease from crab testes | |
JPH0422559B2 (en) | ||
US4259446A (en) | Process for preparation of deoxyribonucleases | |
JPS5926278B2 (en) | Enzymatic production method of known base sequence oligonucleotides | |
JPH01320995A (en) | Production of nucleoside compound | |
US4808531A (en) | New restriction enzyme and process for producing the same | |
JPS5922518B2 (en) | Method for producing polyguanylic acid | |
JP3092817B2 (en) | Method for producing restriction enzyme | |
JPH05236954A (en) | Heat-resistant adenosine-5'-phosphosulfate kinase and its production | |
US4724209A (en) | Process for producing restriction enzyme | |
JPS6178382A (en) | Preparation of restriction enzyme | |
JPH07308194A (en) | Dna sequence, recombinant dna molecule and method for production of enzyme mutarotase from acinetobacter calcoaceticus | |
JPH03112484A (en) | Novel restriction enzyme and its production | |
JPH05137572A (en) | Thermostable adenosine-5'-triphosphate sulfurylase and its production | |
JPS60120981A (en) | Novel strain of brevibacterium acetylicum |